About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
European Journal of Clinical Pharmacology
›
Top Articles
European Journal of Clinical Pharmacology
Pharmacology
2.8
(top 6%)
Impact Factor
3.1
(top 6%)
extended IF
133
(top 2%)
H-Index
3.6K
authors
9.8K
papers
218.9K
citations
8.5K
citing journals
64.2K
citing authors
Most Cited Articles of European Journal of Clinical Pharmacology
Title
Year
Citations
A Bayesian neural network method for adverse drug reaction signal generation
1998
605
Defective N-oxidation of sparteine in man: a new pharmacogenetic defect
1979
592
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects
2005
537
The clinical pharmacology of 6-mercaptopurine
1992
518
Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
1984
513
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
2008
428
Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers
2000
377
Comparison of fixed interval and visual analogue scales for rating chronic pain
1975
377
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man
1984
352
Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
1990
338
Potentially inappropriate medications in the elderly: a French consensus panel list
2007
318
Determination of drug metabolizing enzymes in needle biopsies of human liver
1972
317
Disposition of quercetin in man after single oral and intravenous doses
1975
313
The efficacy of ginseng. A systematic review of randomised clinical trials
1999
305
Clinical pharmacology and pharmacogenetics of thiopurines
2008
287
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
1989
285
Hepatotoxicity from green tea: a review of the literature and two unpublished cases
2009
282
The absolute bioavailability of caffeine in man
1983
268
Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine
1988
262
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine
1996
261
Pharmacokinetics and organ distribution of intravenous and oral methylene blue
2000
259
Pharmacokinetics of metformin after intravenous and oral administration to man
1979
259
Pharmacokinetics of N-acetylcysteine in man
1986
256
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
2012
252
Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development
2003
250
previous
2012
2013
2014
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.